Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector functionHélène Dumortier, Geertje J D van Mierlo, Deirdre Egan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivityMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
Transplant Immunology|July 22, 2008
Differentially modulated dendritic cells induce regulatory T cells with different characteristicsDave L Roelen, Daniëlle E M van den Boogaardt, Paula P M C van Miert, et al.
Scientific Reports|December 10, 2020
Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell linesLaura Hartmann, Philipp Schröter, Wolfram Osen, et al.
European Journal of Human Genetics : EJHG|April 17, 2008
Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumoursJan Willem F Dierssen, Marjo van Puijenbroek, David A Dezentjé, et al.
European Journal of Immunology|March 20, 2008
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentationMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
Molecular Therapy. Methods & Clinical Development|May 19, 2020
Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor ModelsMatthias Bozza, Edward W Green, Elisa Espinet, et al.
European Journal of Immunology|June 24, 2004
T cell avidity determines the level of CTL activationMatthias Hofmann, Markus Radsak, Gerd Rechtsteiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptidesSander Zwaveling, Sandra C Ferreira Mota, Jan Nouta, et al.
Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector functionHélène Dumortier, Geertje J D van Mierlo, Deirdre Egan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivityMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
Transplant Immunology|July 22, 2008
Differentially modulated dendritic cells induce regulatory T cells with different characteristicsDave L Roelen, Daniëlle E M van den Boogaardt, Paula P M C van Miert, et al.
Scientific Reports|December 10, 2020
Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell linesLaura Hartmann, Philipp Schröter, Wolfram Osen, et al.
European Journal of Human Genetics : EJHG|April 17, 2008
Frequent mutations in the 3'-untranslated region of IFNGR1 lack functional impairment in microsatellite-unstable colorectal tumoursJan Willem F Dierssen, Marjo van Puijenbroek, David A Dezentjé, et al.
European Journal of Immunology|March 20, 2008
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentationMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
Molecular Therapy. Methods & Clinical Development|May 19, 2020
Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor ModelsMatthias Bozza, Edward W Green, Elisa Espinet, et al.
European Journal of Immunology|June 24, 2004
T cell avidity determines the level of CTL activationMatthias Hofmann, Markus Radsak, Gerd Rechtsteiner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptidesSander Zwaveling, Sandra C Ferreira Mota, Jan Nouta, et al.
Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
Pageof 12